Literature DB >> 11544440

Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients.

J L Sanchez1, R M Kruger, S Paranjothi, E P Trulock, J P Lynch, C Hicks, W D Shannon, G A Storch.   

Abstract

We developed a multiplex, quantitative, real-time, polymerase chain reaction assay for cytomegalovirus (CMV) and used it to measure the CMV viral load in weekly blood specimens from 43 lung transplant recipients. The median viral load in blood samples immediately preceding bronchoscopy was 1150 copies/microg human DNA for 12 subjects with pneumonitis compared to 91 copies for 31 subjects without (P=0.02, Mann-Whitney U test). Each log10 increase in CMV viral load resulted in an increase of 1.92 in the odds ratio for CMV pneumonitis (95% confidence interval 1.03-3.56). CMV viral load was elevated (>100 copies/microg human DNA) for a median of 21 days before bronchoscopy in those subjects with pneumonitis versus 0 days in those without (P=0.004). We conclude that the risk of CMV pneumonitis after lung transplantation is related to the level of CMV DNA in blood. Quantitative PCR should be evaluated prospectively for the preemptive management of CMV in lung transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544440     DOI: 10.1097/00007890-200108270-00030

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry.

Authors:  Roy F Chemaly; Belinda Yen-Lieberman; Elias A Castilla; Amy Reilly; Susana Arrigain; Carol Farver; Robin K Avery; Steven M Gordon; Gary W Procop
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 2.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Multi-Site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology.

Authors:  Daynna J Wolff; Denise Lamarche Heaney; Paul D Neuwald; Kathleen A Stellrecht; Richard D Press
Journal:  J Mol Diagn       Date:  2009-03       Impact factor: 5.568

4.  Safety and efficacy of prolonged cytomegalovirus prophylaxis with intravenous ganciclovir in pediatric and young adult lung transplant recipients.

Authors:  John F Spivey; Dana Singleton; Stuart Sweet; Gregory A Storch; Robert J Hayashi; Charles B Huddleston; Lara A Danziger-Isakov
Journal:  Pediatr Transplant       Date:  2007-05

5.  Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients.

Authors:  Haijing Li; J Stephen Dummer; Wray R Estes; Shufang Meng; Peter F Wright; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

6.  Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA.

Authors:  Jason L Sanchez; Gregory A Storch
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

7.  Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay.

Authors:  C Mengelle; K Sandres-Sauné; C Pasquier; L Rostaing; J-M Mansuy; M Marty; I Da Silva; M Attal; P Massip; J Izopet
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

8.  Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients.

Authors:  Giuseppe Gerna; Patrizio Vitulo; Francesca Rovida; Daniele Lilleri; Carlo Pellegrini; Tiberio Oggionni; Giulia Campanini; Fausto Baldanti; M Grazia Revello
Journal:  J Med Virol       Date:  2006-03       Impact factor: 2.327

9.  Respiratory Multiplex Polymerase Chain Reaction: An Important Diagnostic Tool in Immunocompromised Patients.

Authors:  Amarjeet Kaur; Navin Kumar; Sharmila Sengupta; Yatin Mehta
Journal:  Indian J Crit Care Med       Date:  2017-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.